The 'grass is greener' in Canada for cannabis-infused beverages according to this California beverage manufacturer. Here's why.
Imperial Brands' CAD$123 million investment in Auxly Group is another tobacco/cannabis Deal-with-the-Devil
Couche-Tard, a $7.7B food retailing giant with 16,000 stores in 26 countries is committing up to CAD$380 million in capital to cannabis. Big news.
MYM's sale of CAD$25 million in CBD-rich hemp biomass has the Company on track to meet revenue/profit targets.
With few public companies to choose from, one Oregon-based cannabis extraction specialist offers intriguing possibilities for investors.
Canada's legal cannabis industry has recorded its 3rd consecutive month of double-digit sales growth. Sales should accelerate going forward. Higher valuations should follow.
The U.S. market for CBD-based products COULD reach $6 billion by 2025. Is the FDA about to get out of the way?
MediPharm Labs and Valens GroWorks are the two leaders in Canadian cannabis extraction. MediPharm MIGHT be the best value for investors at present.
Alberta leads Canada in opening up a legal cannabis industry. The province is already cashing in. Investors can as well.